{"hands_on_practices": [{"introduction": "Before we can manage a disease, we must understand its story. This practice challenges you to assemble the complex sequence of events, from a single molecule (glucose) to the formation of an atherosclerotic plaque. By connecting concepts like endothelial dysfunction, inflammation, and lipid modification, you will build a foundational understanding of how diabetes accelerates vascular disease [@problem_id:4775482].", "problem": "A patient with long-standing type $2$ diabetes mellitus, elevated systolic blood pressure, and daily cigarette use presents without symptoms. You are asked to reason from core definitions of endothelial biology and well-established observations about atherosclerosis initiation to identify the mechanistic chain that plausibly links persistent hyperglycemia to the earliest stage of plaque formation (fatty streak), and to indicate where coexisting elevated blood pressure and smoking act to modify risk. Base your reasoning on the following foundational facts: the vascular endothelium normally maintains antithrombotic, anti-inflammatory tone with high nitric oxide (NO) bioavailability; early atherogenesis requires endothelial dysfunction with increased permeability and leukocyte adhesion; lipid entry and modification within the intima precede foam cell formation; and mechanical and oxidative stresses modulate endothelial function.\n\nWhich option best represents a scientifically consistent sequence from elevated glucose to plaque initiation and correctly locates the roles of elevated blood pressure and cigarette smoking as covariates?\n\nA. Persistent hyperglycemia promotes formation of Advanced Glycation End products (AGE), activation of Protein Kinase C (PKC), and generation of reactive oxygen species (ROS), which together decrease endothelial nitric oxide (NO) bioavailability and increase endothelin-$1$, vascular cell adhesion molecule-$1$ (VCAM-$1$), and intercellular adhesion molecule-$1$ (ICAM-$1$). The dysfunctional endothelium becomes more permeable, allowing low-density lipoprotein (LDL) entry into the intima, where LDL is oxidized. Upregulated adhesion molecules recruit monocytes that transmigrate, differentiate to macrophages, and take up oxidized LDL via scavenger receptors, forming foam cells and a fatty streak. Elevated blood pressure increases mechanical endothelial injury and permeability, and cigarette smoke increases ROS and LDL oxidation, amplifying these steps.\n\nB. Hyperglycemia mainly causes intracellular sorbitol accumulation in endothelial cells, thickening the basement membrane and thereby preventing LDL entry. Elevated blood pressure reduces endothelial shear stress, and smoking increases prostacyclin, so lipid entry is delayed and plaque initiation occurs later primarily through calcification without inflammation.\n\nC. Hyperglycemia leads to hyperinsulinemia that directly stimulates smooth muscle proliferation to form a fibrous cap before any lipid infiltration. Only after the cap forms do monocytes adhere, and LDL entry is secondary. Elevated blood pressure and smoking exert negligible effects on the earliest events.\n\nD. Hyperglycemia produces Advanced Glycation End products (AGE) that crosslink medial collagen, causing arterial stiffness and aneurysm formation; plaque initiation begins when platelets adhere to exposed collagen without a requirement for oxidized LDL. Smoking lowers oxidative stress by neutralizing free radicals and thus protects against early lesion formation.\n\nE. Persistent hyperglycemia activates Protein Kinase C (PKC) to increase endothelin-$1$ and reduce nitric oxide (NO), which raises permeability and adhesion molecule expression and leads to LDL entry, oxidation, monocyte recruitment, and foam cell formation. However, elevated blood pressure counteracts monocyte transmigration by raising luminal pressure and reduces fatty streak formation, while smoking primarily increases prostacyclin and inhibits LDL oxidation.", "solution": "The problem statement is evaluated as valid. It presents a scientifically grounded, well-posed, and objective question rooted in established principles of pathophysiology. The provided foundational facts are accurate and sufficient to reason toward a correct answer. The task is to identify the correct mechanistic sequence for diabetes-accelerated atherosclerosis and the role of key comorbidities.\n\nThe derivation of the correct mechanism proceeds from first principles, integrating the foundational facts provided in the problem statement with established knowledge in vascular biology.\n\n**1. Primary Pathogenesis initiated by Hyperglycemia:**\nPersistent hyperglycemia is the central metabolic derangement in diabetes mellitus. It initiates vascular damage through several major interconnected pathways within endothelial cells and the vascular wall:\n- **Formation of Advanced Glycation End products (AGEs):** Excess glucose non-enzymatically reacts with proteins, lipids, and nucleic acids to form AGEs. AGEs can bind to their receptor (RAGE) on endothelial cells and macrophages, activating pro-inflammatory signaling cascades (e.g., via NF-κB) and increasing the generation of reactive oxygen species (ROS). AGEs also cross-link long-lived matrix proteins like collagen in the vessel wall, contributing to arterial stiffness and trapping of lipoproteins.\n- **Activation of the Protein Kinase C (PKC) pathway:** Hyperglycemia increases the synthesis of diacylglycerol (DAG), which activates several isoforms of PKC. Activated PKC has numerous downstream effects detrimental to vascular function, including increased production of the potent vasoconstrictor endothelin-$1$ (ET-$1$), decreased production of nitric oxide (NO) via reduced expression and activity of endothelial nitric oxide synthase (eNOS), increased expression of vascular endothelial growth factor (VEGF) which promotes permeability, and activation of pro-inflammatory transcription factors that upregulate adhesion molecules.\n- **Generation of Reactive Oxygen Species (ROS):** The above pathways, along with flux through the polyol and hexosamine pathways, lead to mitochondrial overproduction of superoxide and other ROS. This state of oxidative stress is a final common pathway for glucose-mediated vascular damage. ROS directly damage cellular components and, critically, quench the bioavailability of NO by reacting with it to form peroxynitrite (ONOO⁻). This uncouples eNOS, causing it to produce more superoxide instead of NO, creating a vicious cycle.\n\n**2. Endothelial Dysfunction:**\nThe net effect of these hyperglycemic pathways is a shift in endothelial function from its normal antithrombotic, anti-inflammatory, and vasodilatory state to a prothrombotic, pro-inflammatory, and vasoconstricted state. This is termed \"endothelial dysfunction.\" Key features, as outlined by the foundational facts, include:\n- **Decreased NO Bioavailability:** This is a hallmark of endothelial dysfunction, leading to impaired vasodilation and increased expression of factors promoting inflammation and thrombosis.\n- **Increased Expression of Adhesion Molecules:** Pro-inflammatory signaling upregulates vascular cell adhesion molecule-$1$ (VCAM-$1$) and intercellular adhesion molecule-$1$ (ICAM-$1$) on the endothelial surface.\n- **Increased Endothelial Permeability:** The integrity of the endothelial barrier is compromised, allowing plasma constituents, including lipoproteins, to more easily enter the subendothelial space (tunica intima).\n\n**3. Initiation of the Atherosclerotic Plaque (Fatty Streak):**\nThis dysfunctional endothelial state sets the stage for the first phase of atherogenesis:\n- **Lipid Entry and Modification:** Increased permeability allows low-density lipoprotein (LDL) particles to enter the intima. Here, they are retained by binding to proteoglycans. In the pro-oxidant environment created by hyperglycemia, these trapped LDL particles are oxidized to form oxidized LDL (oxLDL).\n- **Leukocyte Recruitment and Infiltration:** The upregulated adhesion molecules (VCAM-$1$, ICAM-$1$) bind to circulating monocytes. These monocytes then migrate across the endothelium into the intima, a process called transmigration or diapedesis, following a chemotactic gradient established by cytokines and oxLDL itself.\n- **Foam Cell Formation:** Once in the intima, monocytes differentiate into macrophages. Macrophages express \"scavenger receptors\" (e.g., SR-A, CD$36$) that recognize and avidly endocytose modified lipoproteins like oxLDL. They do not have a negative feedback mechanism for cholesterol uptake via these receptors, so they become engorged with lipid, transforming into \"foam cells.\"\n- **Fatty Streak:** The accumulation of these lipid-laden foam cells in the intima forms the fatty streak, the earliest grossly visible lesion of atherosclerosis.\n\n**4. Role of Co-morbidities (Covariates):**\n- **Elevated Blood Pressure (Hypertension):** Hypertension imposes increased hemodynamic (mechanical) stress on the endothelium. This stress, especially in areas of turbulent flow such as arterial bifurcations, directly injures endothelial cells, exacerbates endothelial dysfunction, and further increases permeability to lipids and leukocytes. It acts synergistically with the biochemical insults of hyperglycemia to accelerate the entire process.\n- **Cigarette Smoking:** Tobacco smoke is a complex mixture of thousands of chemicals, including potent oxidants (free radicals). It is a major source of exogenous oxidative stress, which directly amplifies the ROS-mediated damage caused by hyperglycemia. It accelerates LDL oxidation, further reduces NO bioavailability, and is directly toxic to endothelial cells. Nicotine also has adverse hemodynamic and prothrombotic effects. Thus, smoking acts as a powerful amplifier of nearly every step in early atherogenesis.\n\nNow, we evaluate the options based on this derived sequence.\n\n**A. Persistent hyperglycemia promotes formation of Advanced Glycation End products (AGE), activation of Protein Kinase C (PKC), and generation of reactive oxygen species (ROS), which together decrease endothelial nitric oxide (NO) bioavailability and increase endothelin-$1$, vascular cell adhesion molecule-$1$ (VCAM-$1$), and intercellular adhesion molecule-$1$ (ICAM-$1$). The dysfunctional endothelium becomes more permeable, allowing low-density lipoprotein (LDL) entry into the intima, where LDL is oxidized. Upregulated adhesion molecules recruit monocytes that transmigrate, differentiate to macrophages, and take up oxidized LDL via scavenger receptors, forming foam cells and a fatty streak. Elevated blood pressure increases mechanical endothelial injury and permeability, and cigarette smoke increases ROS and LDL oxidation, amplifying these steps.**\nThis option accurately and comprehensively details the accepted pathophysiological sequence. It correctly identifies the main pathways of hyperglycemic damage (AGE, PKC, ROS), their impact on endothelial function (decreased NO, increased adhesion molecules), the subsequent steps of fatty streak formation (LDL entry/oxidation, monocyte recruitment, foam cells), and the synergistic, amplifying roles of hypertension (mechanical stress) and smoking (oxidative stress).\n**Verdict: Correct.**\n\n**B. Hyperglycemia mainly causes intracellular sorbitol accumulation in endothelial cells, thickening the basement membrane and thereby preventing LDL entry. Elevated blood pressure reduces endothelial shear stress, and smoking increases prostacyclin, so lipid entry is delayed and plaque initiation occurs later primarily through calcification without inflammation.**\nThis option contains multiple fundamental errors. While the sorbitol (polyol) pathway is involved in diabetic complications, its effect is not to prevent LDL entry; endothelial dysfunction *increases* permeability. Basement membrane thickening is characteristic of microangiopathy, not the primary mechanism of atherosclerosis initiation. Elevated blood pressure involves *increased* or disturbed, not reduced, shear stress. Smoking *decreases*, not increases, the protective prostacyclin. Atherosclerosis is an inflammatory process from its inception, and calcification is a late-stage event.\n**Verdict: Incorrect.**\n\n**C. Hyperglycemia leads to hyperinsulinemia that directly stimulates smooth muscle proliferation to form a fibrous cap before any lipid infiltration. Only after the cap forms do monocytes adhere, and LDL entry is secondary. Elevated blood pressure and smoking exert negligible effects on the earliest events.**\nThis option reverses the known sequence of events. Lipid infiltration and monocyte recruitment (forming a fatty streak) are the *initiating* steps. Smooth muscle proliferation and fibrous cap formation occur later in lesion progression. Stating that hypertension and smoking have negligible effects on early events is profoundly incorrect, as they are major independent risk factors that accelerate the process.\n**Verdict: Incorrect.**\n\n**D. Hyperglycemia produces Advanced Glycation End products (AGE) that crosslink medial collagen, causing arterial stiffness and aneurysm formation; plaque initiation begins when platelets adhere to exposed collagen without a requirement for oxidized LDL. Smoking lowers oxidative stress by neutralizing free radicals and thus protects against early lesion formation.**\nThis option misrepresents the initiating event. Plaque initiation (fatty streak) does not begin with platelet adherence to exposed medial collagen; that describes thrombosis on a ruptured, advanced plaque. The fatty streak forms under an intact (though dysfunctional) endothelium. The role of oxidized LDL is central to foam cell formation and is incorrectly dismissed. The statement that smoking *lowers* oxidative stress is the opposite of the truth and is a critical scientific error.\n**Verdict: Incorrect.**\n\n**E. Persistent hyperglycemia activates Protein Kinase C (PKC) to increase endothelin-$1$ and reduce nitric oxide (NO), which raises permeability and adhesion molecule expression and leads to LDL entry, oxidation, monocyte recruitment, and foam cell formation. However, elevated blood pressure counteracts monocyte transmigration by raising luminal pressure and reduces fatty streak formation, while smoking primarily increases prostacyclin and inhibits LDL oxidation.**\nThe initial part of the statement, while incomplete (focusing only on PKC), is generally correct. However, the descriptions of the comorbidities are catastrophically wrong. Elevated blood pressure *promotes*, not counteracts, atherogenesis. The idea that it reduces fatty streak formation is contrary to all established evidence. The claims that smoking *increases* prostacyclin and *inhibits* LDL oxidation are also the direct opposite of their known effects.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4775482"}, {"introduction": "Not all cholesterol is created equal; the cholesterol carried in apolipoprotein B-containing particles is the primary driver of atherosclerosis. This exercise guides you to calculate non-high-density lipoprotein cholesterol (non-HDL-C), a comprehensive measure of these harmful lipoproteins, using a simple but powerful calculation derived from first principles. Understanding this metric is key to assessing cardiovascular risk, especially in patients with diabetes [@problem_id:4775468].", "problem": "A $55$-year-old man with type $2$ diabetes mellitus presents for cardiovascular risk assessment after a $12$-hour fast. In the fasting state, plasma triglycerides are carried predominantly by very-low-density lipoprotein (VLDL), and the cholesterol content of VLDL is a small, approximately proportional fraction of the triglyceride mass. Chronic insulin resistance shifts the lipoprotein profile toward apolipoprotein B (ApoB)-containing particles, including low-density lipoprotein (LDL), intermediate-density lipoprotein (IDL), very-low-density lipoprotein remnants, chylomicron remnants, and lipoprotein(a) (Lp(a)). The cholesterol within these ApoB-containing particles is termed non-high-density lipoprotein cholesterol (non-HDL-C), which is the pool most directly implicated in atherogenesis leading to macrovascular complications. The patient’s fasting laboratory values are: total cholesterol $TC = 240$ mg/dL, high-density lipoprotein cholesterol $C_{\\mathrm{HDL}} = 38$ mg/dL, and triglycerides $TG = 320$ mg/dL. Assume triglycerides are below the range where standard fasting approximations break down and that chylomicrons are negligible after the fast.\n\nStarting only from core definitions that total plasma cholesterol is partitioned among lipoprotein classes and that non-HDL-C is the cholesterol carried by ApoB-containing lipoproteins, use the fasting relationship between triglycerides and VLDL cholesterol to reason from first principles and estimate the patient’s non-HDL-C that contributes to atherogenesis. Express your final answer in mg/dL. Round your answer to four significant figures.", "solution": "The problem is valid. It is scientifically grounded in the principles of clinical lipidology and pathophysiology, well-posed with sufficient data for a unique solution, and objective in its language. The provided laboratory values are clinically plausible for a patient with type $2$ diabetes. We may therefore proceed with the solution.\n\nThe central task is to estimate the patient's non-high-density lipoprotein cholesterol ($C_{\\mathrm{non-HDL}}$) by reasoning from first principles. The problem provides two core definitions to serve as the foundation for this reasoning.\n\nThe first principle is that total plasma cholesterol ($TC$) is partitioned among the various classes of lipoproteins. Let $C_i$ represent the cholesterol concentration in lipoprotein class $i$. Then, the total cholesterol is the sum of the cholesterol in all classes. A complete partition would include high-density lipoprotein (HDL), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a) (Lp(a)), among others. Chylomicrons are typically absent in a fasting state of $12$ hours, an assumption explicitly stated in the problem.\n$$\nTC = C_{\\mathrm{HDL}} + C_{\\mathrm{LDL}} + C_{\\mathrm{VLDL}} + C_{\\mathrm{IDL}} + C_{\\mathrm{Lp(a)}} + \\dots\n$$\n\nThe second principle defines non-HDL-C as the cholesterol carried by all apolipoprotein B (ApoB)-containing lipoproteins. As stated in the problem, these include LDL, IDL, VLDL and its remnants, chylomicron remnants, and Lp(a). The only major lipoprotein class that does not contain ApoB is HDL. Therefore, the total cholesterol pool can be conceptually and mathematically divided into two mutually exclusive components: cholesterol contained in HDL particles ($C_{\\mathrm{HDL}}$) and cholesterol contained in all non-HDL particles ($C_{\\mathrm{non-HDL}}$).\n\nBased on this logic, the sum of all cholesterol-containing particles can be written as the sum of these two major partitions:\n$$\nTC = C_{\\mathrm{HDL}} + C_{\\mathrm{non-HDL}}\n$$\nwhere $C_{\\mathrm{non-HDL}}$ is, by definition, the sum of cholesterol concentrations in all ApoB-containing lipoproteins:\n$$\nC_{\\mathrm{non-HDL}} = C_{\\mathrm{LDL}} + C_{\\mathrm{VLDL}} + C_{\\mathrm{IDL}} + C_{\\mathrm{Lp(a)}} + \\dots\n$$\nThis fundamental relationship, $TC = C_{\\mathrm{HDL}} + C_{\\mathrm{non-HDL}}$, allows for the direct calculation of non-HDL-C from the provided laboratory values for total cholesterol and HDL cholesterol. This calculation is not an approximation but is a consequence of the definition of non-HDL-C.\n\nBy rearranging the equation, we can solve for $C_{\\mathrm{non-HDL}}$:\n$$\nC_{\\mathrm{non-HDL}} = TC - C_{\\mathrm{HDL}}\n$$\nThe problem provides the following values:\nTotal cholesterol, $TC = 240 \\, \\text{mg/dL}$\nHigh-density lipoprotein cholesterol, $C_{\\mathrm{HDL}} = 38 \\, \\text{mg/dL}$\n\nSubstituting these values into the derived equation:\n$$\nC_{\\mathrm{non-HDL}} = 240 \\, \\text{mg/dL} - 38 \\, \\text{mg/dL} = 202 \\, \\text{mg/dL}\n$$\nThe information regarding triglycerides ($TG = 320 \\, \\text{mg/dL}$) and the relationship between triglycerides and VLDL cholesterol is relevant for the broader clinical picture and is used in other estimations, such as the Friedewald equation for LDL cholesterol ($C_{\\mathrm{LDL}} \\approx TC - C_{\\mathrm{HDL}} - TG/5$). However, the calculation of non-HDL-C is more direct and does not require the triglyceride value. In fact, non-HDL-C is considered a more accurate predictor of atherosclerotic cardiovascular disease risk than calculated LDL-C, particularly in individuals with elevated triglycerides (hypertriglyceridemia), as is common in type $2$ diabetes. This is because the $TC - C_{\\mathrm{HDL}}$ calculation correctly includes the cholesterol content of all atherogenic remnant lipoproteins, which are often not fully captured in the calculated LDL-C value. The problem correctly guides reasoning toward this more fundamental and clinically robust parameter.\n\nThe final step is to adhere to the specified output format. The problem requires the answer to be rounded to four significant figures. The calculated value is $202$. To express this with four significant figures, we write it as $202.0$.", "answer": "$$\n\\boxed{202.0}\n$$", "id": "4775468"}, {"introduction": "Pathophysiology meets clinical practice in this final exercise. Here, you will apply hemodynamic principles to diagnose Peripheral Artery Disease (PAD), a common macrovascular complication of diabetes. By calculating the Ankle-Brachial Index (ABI) from a patient's blood pressure readings, you will translate the physical consequence of an arterial blockage into a quantitative, clinically meaningful diagnostic score [@problem_id:4775536].", "problem": "A patient with long-standing type 2 diabetes mellitus presents with exertional calf pain and diminished distal pulses on the left. Chronic hyperglycemia is known to accelerate atherosclerosis in large arteries through endothelial dysfunction, inflammation, and plaque formation, producing fixed stenoses that increase hydraulic resistance and reduce distal perfusion pressure. Under laminar flow in a rigid cylindrical conduit, Poiseuille’s relationship implies that resistance increases steeply with decreasing radius, and thus a stenosis produces a measurable systolic pressure drop across the lesion. The Ankle–Brachial Index (ABI) is a noninvasive hemodynamic ratio that compares distal (ankle) to proximal (brachial) systolic pressure to infer the presence and severity of peripheral artery disease (PAD), a macrovascular complication of diabetes.\n\nYou obtain systolic pressures using properly sized cuffs and continuous-wave Doppler:\n\n- Brachial systolic pressures: right arm $132 \\,\\text{mmHg}$, left arm $126 \\,\\text{mmHg}$.\n- Left ankle systolic pressures: dorsalis pedis $112 \\,\\text{mmHg}$ and posterior tibial $76 \\,\\text{mmHg}$.\n- Right ankle systolic pressures: dorsalis pedis $148 \\,\\text{mmHg}$ and posterior tibial $142 \\,\\text{mmHg}$.\n\nUse the standard clinical convention for ankle–brachial index calculation that minimizes underestimation due to segmental disease at the ankle and subclavian stenosis in the arms. Then, classify PAD severity according to established thresholds:\n\n- $\\mathrm{ABI} > 1.40$: noncompressible arteries (medial arterial calcification common in diabetes).\n- $1.00 \\le \\mathrm{ABI} \\le 1.40$: normal.\n- $0.91 \\le \\mathrm{ABI} \\le 0.99$: borderline.\n- $0.41 \\le \\mathrm{ABI} \\le 0.90$: mild-to-moderate PAD.\n- $\\mathrm{ABI} \\le 0.40$: severe PAD.\n\nReport for the left leg only. Express the ABI as a unitless ratio and round to three significant figures. Also encode the PAD severity category as an integer $s$ using the following mapping: normal $s=0$, borderline $s=1$, mild-to-moderate $s=2$, severe $s=3$, noncompressible $s=4$. Present your final result as a row matrix containing $\\mathrm{ABI}$ and $s$.", "solution": "The problem requires the calculation of the Ankle-Brachial Index (ABI) for the left leg and the classification of peripheral artery disease (PAD) severity based on the provided systolic pressure measurements and clinical guidelines.\n\nThe Ankle-Brachial Index is a ratio defined as:\n$$\n\\mathrm{ABI} = \\frac{\\text{Highest Ankle Systolic Pressure}}{\\text{Highest Brachial Systolic Pressure}}\n$$\nThe problem specifies the use of the standard clinical convention to \"minimize underestimation\". This convention dictates that for a given limb, the numerator is the highest systolic pressure measured in that ankle (either dorsalis pedis or posterior tibial artery), and the denominator is the highest systolic pressure measured in either arm (brachial artery). This approach prevents the misclassification of PAD by avoiding artificially low ankle pressures from isolated arterial segments and artificially high ABI values due to subclavian stenosis in one arm.\n\nThe given systolic pressure measurements are:\n- Right arm brachial pressure: $P_{\\text{brach, R}} = 132 \\,\\text{mmHg}$\n- Left arm brachial pressure: $P_{\\text{brach, L}} = 126 \\,\\text{mmHg}$\n- Left ankle dorsalis pedis pressure: $P_{\\text{ankle, L, DP}} = 112 \\,\\text{mmHg}$\n- Left ankle posterior tibial pressure: $P_{\\text{ankle, L, PT}} = 76 \\,\\text{mmHg}$\n\nFirst, we determine the pressure for the denominator of the ABI calculation. This is the higher of the two brachial pressures:\n$$\nP_{\\text{brach, highest}} = \\max(P_{\\text{brach, R}}, P_{\\text{brach, L}}) = \\max(132, 126) = 132 \\,\\text{mmHg}\n$$\n\nNext, we determine the pressure for the numerator of the left ABI calculation. This is the higher of the two systolic pressures measured in the left ankle:\n$$\nP_{\\text{ankle, L, highest}} = \\max(P_{\\text{ankle, L, DP}}, P_{\\text{ankle, L, PT}}) = \\max(112, 76) = 112 \\,\\text{mmHg}\n$$\n\nNow we can calculate the ABI for the left leg ($\\mathrm{ABI}_{\\text{L}}$):\n$$\n\\mathrm{ABI}_{\\text{L}} = \\frac{P_{\\text{ankle, L, highest}}}{P_{\\text{brach, highest}}} = \\frac{112}{132}\n$$\nPerforming the division gives:\n$$\n\\mathrm{ABI}_{\\text{L}} \\approx 0.848484...\n$$\nThe problem requires rounding the result to three significant figures. The first three significant figures are $8$, $4$, and $8$.\n$$\n\\mathrm{ABI}_{\\text{L}} \\approx 0.848\n$$\n\nThe final step is to classify the severity of PAD based on the calculated $\\mathrm{ABI}_{\\text{L}}$ and encode it as an integer $s$. The provided thresholds are:\n- $\\mathrm{ABI} > 1.40$: noncompressible ($s=4$)\n- $1.00 \\le \\mathrm{ABI} \\le 1.40$: normal ($s=0$)\n- $0.91 \\le \\mathrm{ABI} \\le 0.99$: borderline ($s=1$)\n- $0.41 \\le \\mathrm{ABI} \\le 0.90$: mild-to-moderate PAD ($s=2$)\n- $\\mathrm{ABI} \\le 0.40$: severe PAD ($s=3$)\n\nOur calculated value $\\mathrm{ABI}_{\\text{L}} = 0.848$ falls within the range $0.41 \\le 0.848 \\le 0.90$. This corresponds to a diagnosis of mild-to-moderate PAD. The integer code for this category is $s=2$.\n\nThe final result is to be presented as a row matrix containing the calculated ABI and the severity code $s$.\nThe two values are $\\mathrm{ABI}_{\\text{L}} = 0.848$ and $s = 2$.", "answer": "$$\n\\boxed{\\begin{pmatrix} 0.848 & 2 \\end{pmatrix}}\n$$", "id": "4775536"}]}